CIK 0001533998
- Non-accelerated filer
- Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 452973162
- Phone
- +972 47706377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- 4 Grant or award Chief Operating Officer acquired 10,000 shares (grant or award)
- 4 Open-market buy Director bought 639 shares at $6.66 ($4,256)
- 4 Open-market buy Director bought 639 shares at $6.66 ($4,256)
- 4 Open-market buy Director bought 15,000 shares
- 4 Open-market buy Director bought 1,450 shares
- 4 Open-market buy Director bought 1,450 shares
- 4 Grant or award Director acquired 2,378 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 1,676 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 15,593 shares
- 4 Open-market buy Director bought 2,378 shares
- 4 Grant or award Director acquired 2,378 shares (grant or award)
- 4 Open-market buy Director bought 2,378 shares
- 4 Grant or award Chief Financial Officer acquired 7,283 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 639 shares at $6.66 ($4,256)
- 4 Open-market buy Director bought 500 shares at $6.50 ($3,250)
- 4 Open-market buy Director bought 1,000 shares at $5.96 ($5,960)
- 4 Open-market buy Director bought 2,500 shares at an average $5.89 ($14,730)
- 4 Open-market buy Chief Executive Officer bought 1,000 shares at an average $6.02 ($6,020)
Page 7 of 20 · 387 filings